Rovi Sees Operating Revenue To Increase By Mid-To High-Single-Digit Percentage Vs 2025

By Reuters News

- Laboratorios Farmaceuticos Rovi, S.A. ROVI.MC:

  • 9-MONTH NET PROFIT €162.8 MILLION

  • 9-MONTH OPERATING REVENUE €610.2 MILLION

  • UPGRADES ITS 2026 OPERATING REVENUE GUIDANCE

  • NOW EXPECTS OPERATING REVENUE TO INCREASE BY A MID-TO HIGH-SINGLE-DIGIT PERCENTAGE COMPARED WITH 2025

  • UPGRADE IS MAINLY RESULT OF STRONGER EXPECTED GROWTH OF THE CDMO BUSINESS

  • WILL PUBLISH ITS 2027 OUTLOOK IN PRESENTATION OF ITS FULL-YEAR 2026 RESULTS, SCHEDULED FOR FEBRUARY 2027

Source text

Further company coverage: ROVI.MC

Capital Com is an execution-only service provider. The present material must be regarded as marketing communication and should not be interpreted as investment research or investment advice. Any opinion that may be provided on this page does not constitute a recommendation by Capital Com or its agents. We do not make any representations or warranty on the accuracy or completeness of the information that is provided on this page. If you rely on the information on this page, then you do so entirely at your own risk